HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Teruyuki Hirano Selected Research

Neoplasms (Cancer)

1/2022Post-Treatment Plasma D-Dimer Levels Are Associated With Short-Term Outcomes in Patients With Cancer-Associated Stroke.
2/2019Subcutaneous Heparin Therapy for Patients with Cancer-Associated Stroke.
4/2013Bilateral basal ganglia lesions as initial manifestation of CNS invasion in adult T-cell leukemia.
1/2012Long-term outcome of polymyositis treated with high single-dose alternate-day prednisolone therapy.
1/2007Paraneoplastic limbic encephalitis caused by ovarian teratoma with autoantibodies to glutamate receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Teruyuki Hirano Research Topics

Disease

50Stroke (Strokes)
01/2024 - 06/2005
37Ischemic Stroke
01/2024 - 04/2005
12Embolic Stroke
02/2024 - 10/2005
12Atrial Fibrillation
01/2022 - 04/2005
9Hemorrhage
12/2023 - 01/2019
8Thrombosis (Thrombus)
01/2022 - 01/2002
7Infarction (Infarctions)
01/2024 - 09/2007
7Transient Ischemic Attack
01/2024 - 06/2005
5Intracranial Hemorrhages (Intracranial Hemorrhage)
12/2023 - 03/2010
5Neoplasms (Cancer)
01/2022 - 01/2007
5Pathologic Constriction (Stenosis)
06/2021 - 05/2002
4Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
10/2023 - 03/2010
3COVID-19
10/2021 - 01/2020
3Cerebral Infarction
01/2019 - 04/2006
3Fever (Fevers)
01/2018 - 02/2006
3Leukocytosis (Pleocytosis)
04/2013 - 08/2007
3Paresis (Hemiparesis)
04/2012 - 07/2002
3Inflammation (Inflammations)
09/2011 - 09/2009
2Brain Infarction
01/2024 - 01/2021
2Cardiovascular Diseases (Cardiovascular Disease)
12/2023 - 12/2020
2Cerebral Small Vessel Diseases
12/2023 - 01/2022
2Cerebral Hemorrhage
10/2023 - 01/2021
2Endocarditis
06/2023 - 01/2013
2Thrombophilia
06/2023 - 01/2022
2Paradoxical Embolism
06/2023 - 09/2007
2Thrombocytopenia (Thrombopenia)
09/2021 - 08/2011
2Hemorrhagic Stroke
07/2021 - 06/2016
2Embolism (Embolus)
04/2021 - 06/2016
2Neurodegenerative Diseases (Neurodegenerative Disease)
11/2014 - 05/2011
2Bacteremia
01/2013 - 02/2006
2Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
02/2011 - 05/2010
2Pain (Aches)
01/2011 - 06/2009
2Brain Diseases (Brain Disorder)
12/2010 - 07/2008
2Hypertension (High Blood Pressure)
01/2010 - 08/2005
1Pneumonia (Pneumonitis)
01/2024
1Myocardial Ischemia (Ischemic Heart Diseases)
01/2024
1Atherosclerosis
06/2023
1Patent Foramen Ovale
05/2023
1Albuminuria
01/2022
1Carotid Stenosis (Carotid Artery Stenosis)
06/2021
1Lymphoma (Lymphomas)
06/2021
1Brain Ischemia (Cerebral Ischemia)
04/2021
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
12/2020
1Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
08/2020
1Diabetes Mellitus
08/2020
1Lacunar Stroke
06/2017
1Ulcer
10/2016
1Atherosclerotic Plaque (Atheroma)
10/2016
1Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease)
01/2015
1Corticobasal Degeneration
11/2014
1Tauopathies
11/2014
1Synucleinopathies
11/2014

Drug/Important Bio-Agent (IBA)

16Tissue Plasminogen Activator (Alteplase)FDA Link
10/2023 - 07/2008
13AnticoagulantsIBA
01/2024 - 01/2007
6RivaroxabanIBA
01/2022 - 06/2016
6Warfarin (Coumadin)FDA LinkGeneric
10/2017 - 09/2007
5Anti-Bacterial Agents (Antibiotics)IBA
01/2018 - 01/2005
5Proteins (Proteins, Gene)FDA Link
11/2014 - 08/2007
4Heparin (Liquaemin)FDA LinkGeneric
01/2022 - 08/2011
3fibrin fragment D (D-dimer)IBA
01/2024 - 01/2022
3Fibrinolytic Agents (Antithrombotic Agents)IBA
12/2023 - 01/2011
3SteroidsIBA
09/2011 - 08/2007
2Cilostazol (Pletal)FDA LinkGeneric
02/2024 - 01/2011
2Factor XIa (Coagulation Factor XIa)IBA
01/2024 - 01/2022
2Biomarkers (Surrogate Marker)IBA
05/2021 - 12/2020
2C-Reactive ProteinIBA
01/2018 - 01/2013
2GadoliniumIBA
04/2012 - 06/2005
2Superoxide Dismutase-1IBA
02/2011 - 05/2010
2AutoantibodiesIBA
07/2008 - 01/2007
2Glutamate Receptors (Glutamate Receptor)IBA
07/2008 - 01/2007
1danaparoid (Orgaran)FDA Link
06/2023
1C-Type Lectins (C-Type Lectin)IBA
01/2023
1Contrast MediaIBA
01/2023
1TenecteplaseFDA Link
03/2022
1VaccinesIBA
09/2021
1Hemoglobins (Hemoglobin)IBA
07/2021
1fasudil (AT 877)IBA
10/2019
1SodiumIBA
10/2019
1Antihypertensive Agents (Antihypertensives)IBA
10/2019
1ozagrelIBA
10/2019
1apixabanIBA
01/2017
1CholesterolIBA
10/2016
1Prion ProteinsIBA
01/2015
1Codon (Codons)IBA
01/2015
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
11/2014

Therapy/Procedure

35Therapeutics
02/2024 - 07/2002
19Thrombectomy
10/2023 - 01/2018
7Secondary Prevention
01/2022 - 09/2007
4Stents
03/2022 - 06/2019
3Punctures
10/2023 - 01/2021
3Thrombolytic Therapy
01/2015 - 01/2002
2Activities of Daily Living (ADL)
01/2023 - 09/2012
2Drug Therapy (Chemotherapy)
06/2021 - 04/2013
2Aftercare (After-Treatment)
03/2010 - 11/2002
2Carotid Endarterectomy
10/2005 - 05/2002
1Cell- and Tissue-Based Therapy (Cell Therapy)
01/2024
1Intravenous Administration
01/2024
1PAVE protocol 2 (CODE protocol)
01/2021
1Critical Care (Surgical Intensive Care)
06/2020
1Intravenous Injections
03/2017